Form 4: Balchem Director Kathleen Fish Acquires Restricted Stock
Insider Transaction Report
Balchem Corporation Director Kathleen B. Fish acquired 870 shares of common stock as restricted stock, increasing her direct beneficial ownership to 3,429 shares.
Summary
- Kathleen B. Fish, a Director of Balchem Corporation (BCPC), acquired 870 shares of common stock.
- The transaction occurred on February 11, 2026, and was an acquisition (Code A) of restricted stock.
- The acquisition price for these shares was $0, indicating a grant as part of compensation.
- Following this transaction, Ms. Fish directly beneficially owns a total of 3,429 shares of Balchem common stock.
- The 870 restricted stock shares will vest one year after the grant date, subject to transfer restrictions outlined in the Restricted Stock Grant Agreement.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as a director's acquisition of shares, even through a restricted stock grant, aligns their interests with shareholders and demonstrates continued commitment to the company.
Positives
- The acquisition of 870 shares of common stock by a director, even as a grant, increases their direct stake in the company, aligning their interests with those of shareholders.
- The grant of restricted stock is a common form of executive and director compensation, indicating continued commitment and incentivization.
Future Outlook
The 870 shares of restricted stock granted to Director Kathleen B. Fish are scheduled to vest one year from the grant date, on February 11, 2027, subject to the terms of the Restricted Stock Grant Agreement.
Industry Context
StockSavvy.ai notes that routine insider transactions, such as restricted stock grants to directors, are common practices in corporate compensation structures. While not typically a major market mover, such grants generally signal continued alignment of management and director interests with long-term shareholder value.
Stakeholder Impact
- Shareholders may view the director's increased beneficial ownership as a positive sign of confidence in the company's future performance.
Next Steps
- The 870 restricted stock shares will vest on February 11, 2027, at which point they will no longer be subject to vesting restrictions.
Key Dates
| Date | Description |
|---|---|
| 02/11/2026 | Date of transaction (acquisition of restricted stock grant) |
| 02/13/2026 | Date the Form 4 was signed |
| 02/11/2027 | Vesting date for the 870 restricted stock shares (1 year following grant date) |
Keywords
Balchem, BCPC, Kathleen Fish, Director, Insider Transaction, Form 4, Restricted Stock, Stock Grant, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.